Target intelligence / Profile preview

Bruch's membrane

Molecular classification
Other (Extracellular matrix structure), Basement membrane (specialized type)
01

Overview

Bruch's membrane is a thin (2–4 μm), acellular, five-layered extracellular matrix located between the retinal pigment epithelium (RPE) and the choriocapillaris within the eye. It serves as a semi-permeable barrier that regulates the exchange of nutrients, oxygen, metabolic waste products, lipids, vitamins, signaling molecules, and other factors essential for photoreceptor function between the retina/RPE complex and general circulation. The structure consists of five layers—two basement membranes on either side sandwiching collagenous zones with a central elastic fiber band. With age or disease states such as age-related macular degeneration or inherited disorders like pseudoxanthoma elasticum or Alport syndrome, Bruch’s membrane can thicken or accumulate lipid-rich deposits ("drusen"), impairing its transport functions. This dysfunction contributes to vision loss through mechanisms such as neovascularization or detachment of retinal layers. While crucial in ocular physiology and pathology—especially in diseases like AMD—Bruch’s membrane itself is not considered a direct therapeutic target like receptors or enzymes but rather an anatomical substrate involved in disease processes.[1][3][5]

Other names
Lamina vitreaVitreous laminaMembrane vitriaeLamina basalis choroideae (Latin)
02

Biological functions

Regulation of fluid and solute passage between the choroid and retina[1][3][5]Physical support for retinal pigment epithelium (RPE) cells[6]Acts as a molecular sieve for biomolecules, nutrients, oxygen, fluids, and metabolic waste products[3][5]Involved in cell–cell communication and tissue remodeling in the eye[6]
03

Disease associations

Age-related macular degeneration (AMD)[1][3][5]Retinitis pigmentosa[3]Pseudoxanthoma elasticum[1][3]Sorsby's fundus dystrophy[3]Malattia Leventinese[3]Myopia-related pathology and trauma-induced defects leading to choroidal neovascularization[1]
04

Biomarkers

Drusen formation as an indicator of AMD progression related to Bruch's membrane changes[1][3]

Beyond the preview

Go deeper on Bruch's membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bruch's membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call